Navigation Links
Omega-3 EPA/DHA May Decrease Risk of Developing Prostate Cancer

DARTMOUTH, NS, April 7 /PRNewswire/ - A new study presented in Clinical Cancer Research, a journal of the AACR (American Association for Clinical Cancer Research), shows diets high in Omega-3 EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) may decrease the risk of prostate cancer. This link appears to be most apparent in those individuals with a genetic tendency towards developing the disease.

While there is no one, single cause of prostate cancer, there are several factors that appear to increase the risk of developing it, including diet. In the study, researchers from the University of California, San Francisco, looked at 466 men with aggressive prostate cancer and 478 healthy men, assessing their eating habits using a food frequency questionnaire. The men were also screened for a variant of a gene known as COX-2, which helps regulate inflammation in the body. A certain variant of this gene is known to increase the risk of developing prostate cancer.

The study shows that those men who ate dark, fatty fish one to three times per month had a 36 percent lower risk of prostate cancer as compared to those who had zero dark fish consumption. Furthermore, those who ate dark fish at least once a week had a 57% risk reduction. And, those who consumed little to no Omega-3 EPA/DHA and who also carried the specific COX-2 variant, were five times more likely to develop advanced prostate cancer. However, this association was essentially reversed with increasing consumption of Omega-3 EPA/DHA.

"This study adds to the growing research that shows that regular Omega-3 EPA/DHA consumption by men may lower their risk of developing prostate cancer," said Ocean Nutrition Canada's Vice President, Marketing and Communications, Lori Covert. "This is definitely positive news."

According to the Canadian Cancer Society, prostate cancer is the most common cancer among Canadian men, with an estimated 24,700 men developing the disease in 2008. In the US, the American Cancer Society's Cancer Facts and Figures 2008 lists prostate cancer as the most diagnosed cancer in American men. The society also ranks prostate cancer as the second most diagnosed and the sixth leading cause of death by cancer among men globally.

In addition to helping lower the risk of developing prostate cancer, Omega-3 EPA/DHA has proven heart health benefits and may reduce the risk of esophageal and colorectal cancer. Additionally, research suggests Omega-3 EPA/DHA may improve cognitive function and symptoms of attention deficit hyperactivity disorder (ADHD), contribute to weight loss, reduce symptoms of depression, and lower the risk of stroke.

About Omega-3:

Omega-3 is an essential fatty acid (EFA), consisting of EPA (eicosapentaenoic acid), DHA (docosahexaenoic acid), and ALA (alpha-linolenic acid). Oily fish, including anchovies, sardines, mackerel, and salmon, are the only known natural sources of Omega-3 EPA/DHA. ALA is found in plants, such as flax and chia. It is important to note that only EPA and DHA contribute to the many health benefits associated with Omega-3. While the body can convert ALA into EPA/DHA, it does so very inefficiently (less than one percent), making it impossible to derive Omega-3-related health benefits from plant sources. Furthermore, although Omega-3 EPA/DHA is vital to overall good health, the human body is not able to produce it on its own, so supplementation is required, either by eating oily fish or foods fortified with Omega-3 EPA/DHA, or by taking fish oil supplements. Learn more about the health benefits of Omega-3 EPA/DHA at

About Ocean Nutrition Canada Limited (ONC):

Ocean Nutrition Canada (ONC) is a privately held company, whose major shareholder is Clearwater Fine Foods Incorporated. Clearwater Fine Foods Incorporated is a diversified holding/investment company whose significant holdings include a controlling interest in Clearwater Seafood's Limited Partnership, the world's largest integrated shellfish harvester and processor.

ONC is a global leading supplier of Omega-3 EPA and DHA ingredients from fish oil...essential nutrients that have been scientifically linked to supporting heart health, brain health, and general wellness. ONC markets its MEG-3(R) ingredients into the Dietary Supplement and Healthy Food markets. To date MEG-3(R) ingredients have been included in over 40 billion servings of food and supplement products world wide. For more information on Ocean Nutrition Canada Limited visit, and for more information on the health benefits of Omega-3 EPA/DHA please visit

SOURCE Ocean Nutrition Canada Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Omega-3s May Benefit Newborns, Menopausal Women and Obese Individuals
2. Omega-3s of No Added Benefit to Heart Attack Patients
3. Omega-3 Fatty Acids Guard Against Advanced Prostate Cancer
4. Omega-3 fatty acids reduce risk of advanced prostate cancer
5. North American Children are Omega-3 Deficient and may be at risk for Suboptimal Health
6. Dr. William Sears and Ocean Nutrition take flight on American Airlines to Spread Consumer Awareness of the Health Benefits of Omega-3 EPA/DHA
7. Nordic Naturals Becomes the Official Omega-3 of the American Pregnancy Association
8. Omega-3s ease depressive symptoms related to menopause
9. Omega-3 Fatty Acid May Help Preemie Girls Brains
10. Three Times More Powerful Than Fish Oil, MegaRed(TM) Omega-3 Krill Oil Now Available Nationwide
11. Fishing for Opportunities in the Omega-3 Ingredients Market
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... The American Society for Clinical Pathology ... World AIDS Day 2015. On Nov. 30, ASCP shared its “Give a minute. Get ... AIDS Day and the importance of getting tested for HIV. , ASCP has asked ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... While powdered ... results in wasted time. Fortunately, an inventor from Chesterfield, Va., has found an easy ... to keep the scoop used to measure powdered contents in a canister or other ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... to its industry-leading suite of automated breast density assessment and enterprise analytics ... meeting, November 29-December 4, 2015 (South Hall booth #2377). Volpara’s quantitative breast ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... for “Value-Based Payer-Provider Partnerships: Three Case Studies,” an upcoming Dec. 8 virtual ... Essentia Health and UCare, MissionPoint Health Partners, and Intel Corp. Leaders from ...
(Date:11/30/2015)... ... November 30, 2015 , ... Insightra Medical, Inc. ... Surgical Mesh technology for soft tissue repair in the US via Insightra’s national ... resorbable surgical mesh intended to support and reinforce soft tissue for 6-9 months ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... HANOVER, N.J. , Nov. 30, 2015  Novartis ... portfolio at the 57 th American Society of ... leukemias, lymphomas and myelomas as well as supportive care, ... in addition to personalized cell therapies. The ASH Annual ... Orlando, Florida . Novartis Oncology . ...
(Date:11/30/2015)... and BOSTON , November 30, 2015 ... develop potential new medicines directed at up to 10 ... --> PFE ) to research and develop ... protein-coupled receptor (GPCR) targets across multiple therapeutic areas. ... drug discovery and development company and wholly-owned subsidiary of ...
(Date:11/30/2015)... 2015 Elbit Imaging Ltd. (TASE, ... today that it was informed by InSightec Ltd. ("InSightec"), that ... has approved its Exablate Neuro system to treat movement, ... --> Insightec,s Exablate Neuro platform is transforming ... two technologies: Focused Ultrasound, which is used to lesion ...
Breaking Medicine Technology: